Riskpilot← Back to searchSign inGet full accessXatrac AB
ABActiveOrg 5590512132Hästhagsvägen 12Medical specialists activities · NACE 8622Est. 20161 employees
Revenue 2024
SEK 2,5M
-4% vs 2023
EBITDA margin
38.0%
+7% vs 2023
Equity ratio
25.1%
Financial strength
Net profit 2024
SEK 563K
+47% vs 2023
| Revenue | SEK 2,5M | -4% |
| EBITDA | SEK 944K | +7% |
| Net profit | SEK 563K | +47% |
| Total assets | SEK 4,2M | +7% |
| Equity | SEK 1M | +18% |
| Employees | 1 | — |
Legal name
Xatrac AB
Org number
5590512132
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 februari 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva konsultverksamhet inom radiologi och medicinsk rådgivning, samt därmed förenlig verksamhet. Bolaget ska bedriva handel med hälsoprodukter. Bolaget skall även bedriva handel och uthyrningsverksamhet av semesterbostäder i Sverige och utomlands. Utöver detta ska bolaget även köpa, sälja, äga, förvalta aktier, värdepapper, fastigheter, bolag, kommersiella samt därmed förenlig verksamhet
Address
Hästhagsvägen 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 852 | 2 408 | 2 516 | 2 594 | 2 486 |
| Staff expenses | — | — | −1 196 | −1 298 | −1 271 |
| EBITDA | 531 | 753 | 1 118 | 886 | 944 |
| Depreciation & amort. | −4 | −4 | −116 | −118 | −121 |
| EBIT | 527 | 749 | 1 002 | 767 | 823 |
| Net financials | −1 | −1 | −1 | 8 | 14 |
| Profit before tax | 488 | 562 | 706 | 535 | 768 |
| Tax | −144 | −154 | −184 | −152 | −205 |
| Net profit | 344 | 408 | 522 | 383 | 563 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 276 | 2 723 | 3 343 | 3 918 | 4 183 |
| Equity | 523 | 682 | 904 | 887 | 1 050 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 776 | 696 | 615 | 783 | 632 |
| Total debt | 776 | 696 | 615 | 783 | 632 |
EBITDA margin
38.0%
This company
15.8%
Market median
+141% vs market
20202024
Equity ratio
25.1%
This company
38.2%
Market median
-34% vs market
20202024
Return on equity
53.6%
This company
18.4%
Market median
+191% vs market
20202024
Net profit margin
22.6%
This company
8.1%
Market median
+179% vs market
20202024
Asset turnover
0.59×
This company
1.12×
Market median
-47% vs market
20202024
Debt / equity
2.98×
This company
0.62×
Market median
-381% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Xatrac AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Laila Viktoria Lindberg Martinell | Board of Directors | 0 companies |
| Axel Martinell Bruckle | Chairman | 0 companies |
| Oddin Axel Cesar Martinell | Deputy Board Member | 0 companies |